Horizon Research Group, LLC
Coral Gables, Florida, United States
Research institute in Coral Gables, Florida
717 Ponce de Leon, Coral Gables, FL 33134
About Horizon Research Group, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Apellis Pharmaceuticals, Inc.
1
Ardelyx
1
Boehringer Ingelheim
1
Regulus Therapeutics Inc.
1
Vertex Pharmaceuticals Incorporated
1
Clinical Trials at Horizon Research Group, LLC
During the past decade, Horizon Research Group, LLC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
2018-01-22
2023-12-01
Active, not recruiting
21
A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia
2021-01-11
2022-03-03
Completed
109
A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
2022-01-11
2023-07-04
Active, not recruiting
714
Phase 2/3 Adaptive Study of VX-147 in Adults and Adolescents With APOL1- Mediated Proteinuric Kidney Disease
2022-03-30
2026-06-01
Recruiting
466
A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease
2022-10-06
2023-12-01
Recruiting
36
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Horizon Research Group, LLC" #1 sponsor was "Apellis Pharmaceuticals, Inc." with 1 trials, followed by "Ardelyx" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Regulus Therapeutics Inc." with 1 trials sponsored and "Vertex Pharmaceuticals Incorporated"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Horizon Research Group, LLC
According to Clinical.Site data, the most researched conditions in "Horizon Research Group, LLC" are
"ADPKD" (1 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "C3 Glomerulonephritis" (1 trials), "Dense Deposit Disease" (1 trials) and "Hyperkalemia" (1 trials). Many other conditions were trialed in "Horizon Research Group, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Horizon Research Group, LLC
Most popular intervention types in "Horizon Research Group, LLC" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "APL-2" (1 trials), "BI 690517" (1 trials), "Empagliflozin" (1 trials) and "Placebo to BI 690517" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Horizon Research Group, LLC
The vast majority of trials in "Horizon Research Group, LLC" are
5 trials for "All" genders.
Clinical Trials Status at Horizon Research Group, LLC
Currently, there are NaN active trials in "Horizon Research Group, LLC".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Horizon Research Group, LLC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Horizon Research Group, LLC, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".